Prevention of diabetic keratopathy
- PMID: 15722297
- PMCID: PMC1772568
- DOI: 10.1136/bjo.2004.055541
Prevention of diabetic keratopathy
Comment on
-
A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.Br J Ophthalmol. 2005 Mar;89(3):266-8. doi: 10.1136/bjo.2004.049841. Br J Ophthalmol. 2005. PMID: 15722300 Free PMC article. Clinical Trial.
References
-
- Gekka M, Miyata K, Nagai Y, et al. Corneal epithelial barrier function in diabetic patients. Cornea 2004;23:35–7. - PubMed
-
- Gobbels M, Spitznas M, Oldendoerp J. Impairment of corneal epithelial barrier function in diabetics. Graefes Arch Clin Exp Ophthalmol 1989;227:142–4. - PubMed
-
- Yokoi N, Niiya A, Komuro A, et al. Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats. Curr Eye Res 1997;16:595–9. - PubMed
-
- Tsubota K, Yamada M. The effect of aldose reductase inhibitor on the corneal epithelium. Cornea 1993;12:161–2. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources